HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Miyasaka Selected Research

K Miyasaka Research Topics

Disease

13Neoplasms (Cancer)
11/2001 - 03/2000
4Prostatic Neoplasms (Prostate Cancer)
12/2000 - 05/2000
2Leukoencephalopathies
07/2003 - 12/2002
2Brain Death (Brain Dead)
10/2000 - 08/2000
2Edema (Dropsy)
07/2000 - 04/2000
2Carcinoma (Carcinomatosis)
04/2000 - 02/2000
1Obesity
09/2006
1Bulimia Nervosa
09/2006
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
05/2004
1Wasting Syndrome (Wasting Disease)
05/2004
1Inappropriate ADH Syndrome (SIADH)
05/2004
1Dehydration (Water Stress)
05/2004
1Hyponatremia
05/2004
1Aneurysm (Aneurysms)
12/2001
1Smear Layer
11/2001
1Acute Lung Injury
10/2001
1Pneumonia (Pneumonitis)
10/2001
1Spinal Cord Compression
09/2001
1Polyuria
08/2001
1Brain Diseases (Brain Disorder)
08/2001
1Bradycardia
08/2001
1Oliguria
08/2001
1Central Nervous System Neoplasms
07/2001
1Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2001
1Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
06/2001
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2001
1Squamous Cell Carcinoma of Head and Neck
02/2001
1Adenocarcinoma
01/2001
1Adenocarcinoma of Lung
01/2001
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2000
1Acoustic Neuroma (Acoustic Neurinoma)
12/2000
1Lung Neoplasms (Lung Cancer)
11/2000
1Leukemia
10/2000
1Respiratory Insufficiency (Respiratory Failure)
10/2000
1Breast Neoplasms (Breast Cancer)
10/2000
1Heart Failure
08/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2000
1Pancreatitis
07/2000
1Hemorrhage
05/2000
1Disease Progression
05/2000

Drug/Important Bio-Agent (IBA)

2GoldIBA
10/2001 - 09/2000
1Ghrelin ReceptorsIBA
09/2006
1Adrenergic Receptors (Adrenergic Receptor)IBA
09/2006
1Cholecystokinin (Pancreozymin)IBA
09/2006
1Cholecystokinin A ReceptorIBA
09/2006
1SodiumIBA
05/2004
1Vasopressins (Vasopressin)IBA
05/2004
1SaltsIBA
05/2004
1Hypotonic SolutionsIBA
05/2004
1Methotrexate (Mexate)FDA LinkGeneric
07/2003
1Fluorouracil (Carac)FDA LinkGeneric
12/2002
1PlasticsIBA
12/2001
1hydroxyethyl methacrylate (HEMA)IBA
11/2001
1Phenyl-P adhesion promoting monomerIBA
11/2001
12-methacryloyloxyethyl phenyl phosphoric acidIBA
11/2001
1AcetoneIBA
11/2001
1Edetic Acid (EDTA)FDA Link
11/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001
1DevazepideIBA
08/2001
1ElectrolytesIBA
08/2001
1Tacrolimus (Prograf)FDA LinkGeneric
08/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2001
1Tumor Biomarkers (Tumor Markers)IBA
11/2000
1ChromatinIBA
10/2000
1Proteins (Proteins, Gene)FDA Link
10/2000
1Radioisotopes (Radionuclides)IBA
10/2000
1soblidotin (TZT 1027)IBA
10/2000
1Antineoplastic Agents (Antineoplastics)IBA
10/2000
1Caspase 3 (Caspase-3)IBA
10/2000
1LipopolysaccharidesIBA
07/2000
1Interleukin-6 (Interleukin 6)IBA
07/2000
1AntibodiesIBA
07/2000
1CeruletideIBA
07/2000

Therapy/Procedure

15Radiotherapy
10/2001 - 02/2000
4Particle Accelerators
10/2001 - 09/2000
3Aftercare (After-Treatment)
08/2001 - 12/2000
3Conformal Radiotherapy
07/2001 - 09/2000
2Therapeutics
08/2000 - 07/2000
1Fluid Therapy (Oral Rehydration Therapy)
05/2004
1Local Anesthesia
11/2001
1Cryosurgery
11/2001
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
10/2001
1Prostheses and Implants (Prosthesis)
10/2000
1Spinal Fusion (Spondylosyndesis)
10/2000
1Heart Transplantation (Grafting, Heart)
08/2000
1Organ Transplantation
08/2000
1Injections
07/2000